Review
Accepted on 29 Jan 2026
Chronic Inflammation as a Driving Factor for Sarcopenia: An Update on Pathophysiology and Future Therapeutic Targets
in Inflammation Pharmacology
- 292 views
Review
Accepted on 29 Jan 2026
in Inflammation Pharmacology
Original Research
Accepted on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Accepted on 29 Jan 2026
in Experimental Pharmacology and Drug Discovery
Correction
Published on 29 Jan 2026
in Ethnopharmacology
Review
Published on 29 Jan 2026
in Experimental Pharmacology and Drug Discovery
Retraction
Published on 29 Jan 2026
in Ethnopharmacology
Mini Review
Published on 29 Jan 2026
in Gastrointestinal and Hepatic Pharmacology
Mini Review
Published on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 Jan 2026
in Pharmacoepidemiology
Editorial
Published on 29 Jan 2026
in Experimental Pharmacology and Drug Discovery
Systematic Review
Published on 29 Jan 2026
in Drugs Outcomes Research and Policies
Review
Published on 29 Jan 2026
in Ethnopharmacology
Review
Published on 29 Jan 2026
in Neuropharmacology
Systematic Review
Published on 29 Jan 2026
in Gastrointestinal and Hepatic Pharmacology
Review
Published on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 29 Jan 2026
in Pharmacology of Anti-Cancer Drugs
Retraction
Published on 29 Jan 2026
in Experimental Pharmacology and Drug Discovery
Review
Published on 29 Jan 2026
in Ethnopharmacology
Original Research
Published on 29 Jan 2026
in Ethnopharmacology
Original Research
Published on 29 Jan 2026
in Neuropharmacology
Brief Research Report
Published on 29 Jan 2026
in Experimental Pharmacology and Drug Discovery
Original Research
Accepted on 28 Jan 2026
in Neuropharmacology
Original Research
Accepted on 28 Jan 2026
in Neuropharmacology
Original Research
Accepted on 28 Jan 2026
in Neuropharmacology